Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Income (Loss)

v3.7.0.1
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Income Statement [Abstract]      
Grant revenues $ 78 $ 9
Operating expenses      
Research and development 101,679 47,261 4,071
General and administrative 4,140 6,765 1,737
Total operating expenses 105,819 54,026 5,808
Loss from operations (105,819) (53,948) (5,799)
Interest income 126 180 96
Realized gain on marketable securities 1,359
Other expense (1) (7)
Fair value of warrant liabilities in excess of proceeds from financing (946)
Loss on return of escrowed shares (1,686) (584)
Impairment loss on mortgage note receivable (1,177)
Change in fair value of derivative liabilities 2,603 (9,916) 5,730
Total other income (expense), net 1,551 (11,422) 5,648
Loss before income taxes (104,268) (65,370) (151)
Income tax benefit 29,394 15,248 52
Net loss (74,874) (50,122) (99)
Comprehensive income (loss):      
Net loss (74,874) (50,122) (99)
Unrealized gain on marketable securities, net of tax 236
Total comprehensive income (loss) $ (74,874) $ (50,122) $ 137
Net loss per common share:      
Net loss per share, basic $ (0.11) $ (0.08) $ (0.00)
Net loss per share, diluted $ (0.11) $ (0.08) $ (0.01)
Weighted average common shares outstanding, basic 705,529,000 630,316,000 326,779,000
Weighted average common shares outstanding, diluted 706,000,000 630,316,000 327,753,000